OracleBio analysis data is presented at at American Society of Clinical Oncology (ASCO) in June 2022.
The poster, presented by Marie Cumberbatch from TriStar Technology Group, is collaborative work between TriStar, Ultivue, and OracleBio.
The work involved multiplex IF staining and analysis of multi-tumor tissue microarrays, with this poster focusing on the contribution of macrophages to the overall tumor PD-L1 microenvironment across different cancer types.
Such target prevalence data can help guide options for successful immunotherapy strategies.
Click the thumbnail image below to view or download the high-resolution poster PDF:
More from OracleBio:
High ICOS/FOXP3 Tregs Content in the Tumor Microenvironment is Associated with Poorer Survival in Patients with Hepatocellular Carcinoma
OracleBio data quantifying ICOS and FoxP3 dual IHC in clinical HCC samples is presented on a collaborative poster at the AACR 2020 Virtual Annual Meeting. The poster, produced in collaboration with Kymab and the National Taiwan University Hospital, explores the...
Applying deep learning classification for tumor identification across immunohistochemical markers on serial sections to eliminate the need for image co-registration
OracleBio presented a poster at the Society for Immunotherapy of Cancer Annual Meeting 2019 on the 6th – 10th November. The poster is entitled ‘Applying deep learning classification for tumor identification across immunohistochemical markers on serial sections to...
Characterization of Anti-CTLA-4 Effects on Tumor Growth and Immune Microenvironment in a Syngeneic CT26.WT Colon Carcinoma Mouse Model
In collaboration with Pharmatest, OracleBio presented a poster at the AACR Annual Meeting 2019, which took place from the 29th of March to the 3rd of April 2019. The poster is entitled ‘Characterization of Anti-CTLA-4 Effects on Tumor Growth and Immune...
Learn More About OracleBio's Multiplex IF Analysis
Explore OracleBio's Scientific Posters
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more



